Commission to invest €97 million to help 64 small businesses bring their innovations to the market

On 17 July the European Commission announced that 64 small and medium-sized companies (SMEs) from 16 countries were selected for funding in the Phase 2 of the Horizon 2020 SME Instrument.

The total amount that will be distributed between the SMEs working on 57 projects is € 96.815 million. In phase 2 of the SME instrument, each project will receive up to €2.5 million (€ 5 million for health projects) to finance innovation activities.
Among the SMEs, the most successful ones were from Spain with 12 companies selected for funding. The other most successful countries were Denmark (8 companies) and France and Italy (with each 7 businesses). Most projects are in the field of transport (10 projects) and ICT (9 projects).

Background:

  • By 1 June 2017, the European Commission received 1 514 project proposals. Since the launch of the programme on 1st January 2014, 774 SMEs have been selected for funding under Phase 2.
  • Phase 2 funding will allow companies to invest in innovation activities such as demonstration, testing, piloting, scaling up and miniaturisation, in addition to developing a mature business plan for their product. Another benefit is a 12 days business coaching for the companies.

The next cut-off for Phase 2 is on 18 October 2017.

More information can be found here.


Date: 03/08/2017 | Tag: | News: 635 of 1626
All news

News

  • 05/11/2024

    "In silico trials: an updated SWOT Analysis" released by In Silico World

    • The document comprehensively examines the strengths, weaknesses, opportunities, and threats for In Silico Trials in healthcare, providing a roadmap to help biomedical companies navigate and adopt these innovative methodologies. -Read more-
  • 31/10/2024

    In the literature: October 2024 highlights

    • Click here to read some interesting recently published papers from our community. If you have published an article in the field of in silico medicine, send it to us: we will include it in this section of the newsletter! -Read more-
  • 31/10/2024

    Joint motion for a resolution to revise the Medical Devices Regulation

    • The European Parliament has voted with a large majority to urge the European Commission to implement critical amendments to the EU Medical Device Regulation (MDR) by the first quarter of 2025. The drive for reform is intended to tackle pressing issues in the regulation, which has been criticised for its excessive bureaucracy and impact on patient care, jobs, and innovation in the medical device sector. -Read more-
  • 31/10/2024

    EU Budget for 2025 Prioritizes Research, Health, Education, and Climate Action

    • The European Parliament has presented their draft budget demanding an EU budget for 2025 that focuses on improving people's lives, boosting competitiveness, and addressing current challenges. MEPs are proposing a budget of nearly €201 billion, which exceeds the European Commission's initial proposal of around €199.76 billion. -Read more-
More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

ARCHIVE

Read all the newsletters of the VPH Institute

GO